Patients with decompensated cirrhosis due to non-alcoholic steatohepatitis had worse outcomes and more complications than patients with hepatitis B virus, according to study results.
Hiang Keat Tan, MB, BS, MRCP, from the department of gastroenterology and hepatology at Singapore General Hospital, and colleagues wrote that they expect NASH to become a larger cause of cirrhosis in Asia and sought to determine its potential burden in the future by comparing outcomes with the current driver of liver disease in the region, HBV.